Click on the company or penalty amount for more information on each case. Click on the current parent name to reach the summary page for that parent company.
| Company | Current Parent | Current Parent Industry | Primary Offense Type | Year | Agency | Penalty Amount  |
|---|---|---|---|---|---|---|
| Merck Sharp & Dohme Corp. | Merck | pharmaceuticals | False Claims Act and related | 2012 | KY-AG | $6,000,000 |
| Par Pharmaceutical | Endo International | pharmaceuticals | False Claims Act and related | 2013 | LA-AG | $6,000,000 |
| Pfizer | Pfizer | pharmaceuticals | drug or medical equipment safety violation | 2003 | MULTI-AG | $6,000,000 |
| General Nutrition Centers Inc. | Harbin Pharmaceutical Group | pharmaceuticals | consumer protection violation | 2019 | private lawsuit-federal | $6,000,000 |
| Ultragenyx Pharmaceutical Inc. | Ultragenyx Pharmaceutical | pharmaceuticals | False Claims Act and related | 2023 | DOJ_CIVIL | $6,000,000 |
| Barr Pharmaceuticals | Teva Pharmaceutical Industries | pharmaceuticals | price-fixing or anti-competitive practices | 2008 | MULTI-AG | $5,900,000 |
| Janssen Ortho LLC and Janssen Pharmaceuticals, Inc. | Johnson & Johnson | pharmaceuticals | off-label or unapproved promotion of medical products | 2014 | MT-AG | $5,900,000 |
| Takeda Chemical | Takeda Pharmaceutical | pharmaceuticals | price-fixing or anti-competitive practices | 2000 | CA-AG | $5,850,550 |
| Takeda Pharmaceuticals U.S.A. | Takeda Pharmaceutical | pharmaceuticals | False Claims Act and related | 2019 | IL-AG | $5,833,333 |
| ICN Pharmaceuticals, Inc. | Bausch Health | pharmaceuticals | fraud | 2001 | USAO | $5,600,000 |
| AstraZeneca PLC | AstraZeneca | pharmaceuticals | kickbacks and bribery | 2016 | SEC | $5,522,000 |
| AstraZeneca | AstraZeneca | pharmaceuticals | off-label or unapproved promotion of medical products | 2013 | KY-AG | $5,500,000 |
| Warner Chilcott Holdings | AbbVie | pharmaceuticals | price-fixing or anti-competitive practices | 2007 | MULTI-AG | $5,500,000 |
| Merck & Co. Inc. | Merck | pharmaceuticals | consumer protection violation | 2009 | MULTI-AG | $5,400,000 |
| AstraZeneca | AstraZeneca | pharmaceuticals | consumer protection violation | 2010 | KY-AG | $5,391,000 |
| TAP Pharmaceutical Products | Takeda Pharmaceutical | pharmaceuticals | False Claims Act and related | 2011 | PA-AG | $5,240,797 |
| Johnson & Johnson et al. | Johnson & Johnson | pharmaceuticals | False Claims Act and related | 2010 | HI-AG | $5,200,000 |
| MERCK SHARP & DOHME CORP | Merck | pharmaceuticals | environmental violation | 2006 | PA-ENV | $5,033,000 |
| Dr. Reddy's Laboratories Inc. | Dr. Reddy's Laboratories | pharmaceuticals | drug or medical equipment safety violation | 2018 | DOJ_CIVIL | $5,000,000 |
| Synthes USA | Johnson & Johnson | pharmaceuticals | wage and hour violation | 2016 | private lawsuit-federal | $5,000,000 |
| CIBA Vision | Novartis | pharmaceuticals | price-fixing or anti-competitive practices | 2000 | MULTI-AG | $5,000,000 |
| Ranbaxy | Sun Pharmaceuticals | pharmaceuticals | False Claims Act and related | 2013 | LA-AG | $5,000,000 |
| Schering-Plough | Merck | pharmaceuticals | False Claims Act and related | 2012 | LA-AG | $5,000,000 |
| Taro Pharmaceutical Industries | Sun Pharmaceuticals | pharmaceuticals | False Claims Act and related | 2013 | LA-AG | $5,000,000 |
| Johnson & Johnson Consumer Companies, Inc. | Johnson & Johnson | pharmaceuticals | consumer protection violation | 2017 | private lawsuit-federal | $5,000,000 |
| Dey L.P. | Viatris | pharmaceuticals | False Claims Act and related | 2008 | AL-AG | $4,750,000 |
| Baxalta US Inc. | Takeda Pharmaceutical | pharmaceuticals | wage and hour violation | 2019 | private lawsuit-state | $4,750,000 |
| General Nutrition | Harbin Pharmaceutical Group | pharmaceuticals | wage and hour violation | 2005 | private lawsuit-state | $4,600,000 |
| Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim Roxane, Inc., Roxane Laboratories, Inc. and Ben Venue Laboratories, Inc. | Boehringer Ingelheim | pharmaceuticals | False Claims Act and related | 2009 | KY-AG | $4,500,000 |
| Par Pharmaceutical Inc. | Endo International | pharmaceuticals | False Claims Act and related | 2011 | KY-AG | $4,500,000 |
| Johnson and Johnson | Johnson & Johnson | pharmaceuticals | consumer protection violation | 2009 | WV-AG | $4,475,000 |
| Kos Pharmaceuticals | AbbVie | pharmaceuticals | kickbacks and bribery | 2010 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $4,454,432 |
| Daiichi Pharmaceutical | Daiichi Sankyo | pharmaceuticals | price-fixing or anti-competitive practices | 2000 | MULTI-AG | $4,340,100 |
| Warrick Pharmaceuticals Inc. | Merck | pharmaceuticals | False Claims Act and related | 2009 | OH-AG | $4,300,000 |
| GlaxoSmithKline | GlaxoSmithKline | pharmaceuticals | False Claims Act and related | 2011 | KS-AG | $4,250,000 |
| Merck and Company, Inc. | Merck | pharmaceuticals | False Claims Act and related | 2011 | WI-AG | $4,250,000 |
| Barr Pharmaceuticals Inc. | Teva Pharmaceutical Industries | pharmaceuticals | price-fixing or anti-competitive practices | 2007 | private lawsuit-federal | $4,150,000 |
| Warner Chilcott Holdings Company | AbbVie | pharmaceuticals | price-fixing or anti-competitive practices | 2007 | private lawsuit-federal | $4,150,000 |
| Aegerion Pharmaceuticals | Amryt Pharma | pharmaceuticals | investor protection violation | 2017 | SEC | $4,100,000 |
| Actavis | AbbVie | pharmaceuticals | False Claims Act and related | 2012 | LA-AG | $4,000,000 |
| Apotex | Apotex Corp. | pharmaceuticals | False Claims Act and related | 2013 | LA-AG | $4,000,000 |
| DePuy Orthopaedics Inc. | Johnson & Johnson | pharmaceuticals | drug or medical equipment safety violation | 2014 | OR-AG | $4,000,000 |
| Dey Inc. | Viatris | pharmaceuticals | False Claims Act and related | 2006 | OH-AG | $4,000,000 |
| Shire | Takeda Pharmaceutical | pharmaceuticals | False Claims Act and related | 2013 | LA-AG | $4,000,000 |
| Johnson & Johnson Medical, Inc. | Johnson & Johnson | pharmaceuticals | False Claims Act and related | 2001 | DOJ_CIVIL | $3,900,000 |
| Dey Labs | Viatris | pharmaceuticals | False Claims Act and related | 2009 | MS-AG | $3,900,000 |
| Johnson & Johnson | Johnson & Johnson | pharmaceuticals | drug or medical equipment safety violation | 2020 | WV-AG | $3,900,000 |
| Takeda/Tap Pharmaceuticals | Takeda Pharmaceutical | pharmaceuticals | False Claims Act and related | 2013 | LA-AG | $3,750,000 |
| GlaxoSmithKline | GlaxoSmithKline | pharmaceuticals | off-label or unapproved promotion of medical products | 2010 | KY-AG | $3,700,000 |
| St. Jude Medical Inc. | Abbott Laboratories | pharmaceuticals | False Claims Act and related | 2012 | DOJ_CIVIL | $3,650,000 |
| Bristol-Myers Squibb | Bristol-Myers Squibb | pharmaceuticals | air pollution violation | 2008 | EPA | $3,650,000 |
| Actavis Elizabeth LLC | Teva Pharmaceutical Industries | pharmaceuticals | False Claims Act and related | 2010 | MA-AG | $3,600,000 |
| Eon Labs Inc. | Novartis | pharmaceuticals | False Claims Act and related | 2010 | DOJ_CIVIL | $3,500,000 |
| Mallinckrodt LLC | Mallinckrodt | pharmaceuticals | False Claims Act and related | 2013 | USAO | $3,500,000 |
| Allergan Inc. | AbbVie | pharmaceuticals | False Claims Act and related | 2018 | USAO | $3,500,000 |
| Amgen and Immunex | Amgen | pharmaceuticals | False Claims Act and related | 2008 | AL-AG | $3,500,000 |
| Dey, Inc. | Viatris | pharmaceuticals | False Claims Act and related | 2010 | KY-AG | $3,500,000 |
| GlaxoSmithKline | GlaxoSmithKline | pharmaceuticals | price-fixing or anti-competitive practices | 2006 | MULTI-AG | $3,500,000 |
| Pacira Pharmaceuticals, Inc. | Pacira BioSciences | pharmaceuticals | kickbacks and bribery | 2020 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $3,500,000 |
| Aventis Pharmaceuticals Inc. | Sanofi | pharmaceuticals | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $3,500,000 |
| Ranbaxy Laboratories Ltd. | Sun Pharmaceuticals | pharmaceuticals | price-fixing or anti-competitive practices | 2020 | private lawsuit-federal | $3,500,000 |
| Ortho McNeil Pharmaceutical | Johnson & Johnson | pharmaceuticals | False Claims Act and related | 2009 | DOJ_CIVIL | $3,400,000 |
| Ortho-McNeil Pharmaceutical, Inc. | Johnson & Johnson | pharmaceuticals | False Claims Act and related | 2009 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $3,400,000 |
| UCB | UCB | pharmaceuticals | False Claims Act and related | 2013 | LA-AG | $3,350,000 |
| Pfizer, Inc. | Pfizer | pharmaceuticals | drug or medical equipment safety violation | 2012 | OR-AG | $3,340,000 |
| AstraZeneca Pharmaceuticals, LP | AstraZeneca | pharmaceuticals | False Claims Act and related | 2010 | HI-AG | $3,333,333 |
| GlaxoSmithKline LLC | GlaxoSmithKline | pharmaceuticals | False Claims Act and related | 2010 | HI-AG | $3,333,333 |
| Novartis Pharmaceuticals Corporation | Novartis | pharmaceuticals | False Claims Act and related | 2010 | HI-AG | $3,333,333 |
| Novo Nordisk Inc. | Novo Holdings A/S | pharmaceuticals | False Claims Act and related | 2017 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $3,320,963 |
| Boehringer Ingelheim | Boehringer Ingelheim | pharmaceuticals | False Claims Act and related | 2012 | LA-AG | $3,250,000 |
| Sandoz Inc. | Sandoz Group | pharmaceuticals | price-fixing or anti-competitive practices | 2017 | private lawsuit-federal | $3,202,500 |
| Roxane, Inc. | Hikma Pharmaceuticals | pharmaceuticals | False Claims Act and related | 2010 | MO-AG | $3,100,000 |
| Dey | Viatris | pharmaceuticals | False Claims Act and related | 2012 | LA-AG | $3,000,000 |
| Forest Laboratories | AbbVie | pharmaceuticals | False Claims Act and related | 2013 | LA-AG | $3,000,000 |
| Forest Laboratories | AbbVie | pharmaceuticals | False Claims Act and related | 2013 | TX-AG | $3,000,000 |
| Allergan Inc. | AbbVie | pharmaceuticals | price-fixing or anti-competitive practices | 2018 | private lawsuit-federal | $3,000,000 |
| Dey Inc. | Viatris | pharmaceuticals | False Claims Act and related | 2006 | MO-AG | $2,932,000 |
| Dey, Inc. | Viatris | pharmaceuticals | False Claims Act and related | 2007 | MA-AG | $2,900,000 |
| Pfizer Inc. and Pharmacia Corp. | Pfizer | pharmaceuticals | False Claims Act and related | 2012 | ID-AG | $2,900,000 |
| Glenmark Pharmaceuticals, Inc. | Glenmark Pharmaceuticals | pharmaceuticals | HHS civil monetary penalties | 2015 | HHSOIG | $2,887,300 |
| Cypress Pharmaceutical Inc. | Currax Pharmaceuticals | pharmaceuticals | off-label or unapproved promotion of medical products | 2012 | FDA | $2,800,000 |
| Novartis Pharmaceuticals Corp. | Novartis | pharmaceuticals | False Claims Act and related | 2012 | KY-AG | $2,750,000 |
| Aegerion Pharmaceuticals Inc. | Amryt Pharma | pharmaceuticals | False Claims Act and related | 2017 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $2,700,000 |
| EMD Millipore Corporation | Merck KGaA (EMD) | pharmaceuticals | pesticide violation | 2013 | EPA | $2,681,500 |
| EMD MILLLIPORE CORP | Merck KGaA (EMD) | pharmaceuticals | environmental violation | 2013 | EPA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $2,681,500 |
| AstraZeneca Pharmaceuticals | AstraZeneca | pharmaceuticals | False Claims Act and related | 2009 | DOJ_CIVIL | $2,600,000 |
| Genentech | Roche | pharmaceuticals | wage and hour violation | 2011 | private lawsuit-state | $2,600,000 |
| AstraZeneca Pharmaceuticals LP | AstraZeneca | pharmaceuticals | False Claims Act and related | 2009 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $2,600,000 |
| GlaxoSmithKline | GlaxoSmithKline | pharmaceuticals | False Claims Act and related | 2012 | ID-AG | $2,600,000 |
| Mylan Inc. | Viatris | pharmaceuticals | False Claims Act and related | 2010 | MA-AG | $2,600,000 |
| Eisai Co. | Eisai | pharmaceuticals | price-fixing or anti-competitive practices | 2000 | CA-AG | $2,544,900 |
| AstraZeneca Pharmaceuticals LP and AstraZeneca LP | AstraZeneca | pharmaceuticals | False Claims Act and related | 2011 | ID-AG | $2,500,000 |
| Dey Inc. | Viatris | pharmaceuticals | False Claims Act and related | 2005 | CT-AG | $2,500,000 |
| Pharmacia Corporation | Pfizer | pharmaceuticals | False Claims Act and related | 2011 | NY-AG | $2,500,000 |
| Teva Pharmaceuticals USA | Teva Pharmaceutical Industries | pharmaceuticals | environmental violation | 2013 | MO-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $2,402,793 |
| Amgen, Inc. | Amgen | pharmaceuticals | False Claims Act and related | 2009 | KY-AG | $2,400,000 |
| Roxane Laboratories Inc. | Hikma Pharmaceuticals | pharmaceuticals | False Claims Act and related | 2009 | OH-AG | $2,400,000 |
| Watson Pharmaceuticals, Inc. | Teva Pharmaceutical Industries | pharmaceuticals | False Claims Act and related | 2010 | MA-AG | $2,400,000 |
| Johnson & Johnson Consumer Companies, Inc. | Johnson & Johnson | pharmaceuticals | consumer protection violation | 2019 | private lawsuit-federal | $2,400,000 |
| Bristol-Myers Squibb | Bristol-Myers Squibb | pharmaceuticals | air pollution violation | 2009 | EPA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $2,328,154 |
| Endo International plc | Endo International | pharmaceuticals | price-fixing or anti-competitive practices | 2019 | MULTI-AG | $2,300,000 |
